MCL1 and posterior cortical atrophy: Furthermore, we demonstrate that therapeutic strategies targeting MCL1 (directly or indirectly) synergize with BCLXL/BCL2 blockade, activating the intrinsic apoptosis pathway to drive PCa cell death in patient-derived and mouse PCa models.